Home > Inhibitors & Agonists > Others
Cat. No. Product name CAS No.
DCC4933 Stat3-in-13r

Novel inhibitor of STAT3, targeting SH2 domain

DCC4934 Stat3-in-3

Novel potent and selective inhibitor of STAT3

2361304-26-7
DCC4935 Stat3-in-a69

Novel inhibitor targeting the DNA-binding domain of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo

1164546-70-6
DCC4936 Stat3-in-b9

Novel inhibitor of signal transducer and activator of transcription 3 (STAT3), inhibiting the proliferation of tumor cells harboring abnormal activation of STAT3, such as, MDA-MB-468, MDA-MB-231 and DU145

825611-06-1
DCC4937 Stat5a-in-27

Novel cell-permeable selective STAT5a inhibitor prodrug, inhibiting tyrosine phosphorylation of STAT5a with selectivity over STAT5b in cultured human leukemia cells, and representing a valuable tool to define the non-redundant molecular functions of the t

DCC4938 Stat5b-in-6a

Highly Potent and Selective Inhibitor of the Transcription Factor STAT5b

DCC4939 Stemazole

Novel human stem/progenitor cells proliferation activator, promoting survival and preserving stemness in human embryonic stem cells

317337-07-8
DCC4940 Sterigmatocystin

Natural inducer of G1 arrest in primary human esophageal epithelial cells but G2 arrest in immortalized cells

10048-13-2
DCC4941 Stf-038533

Novel inhibitor of expression from canonical CREB response element-containing promoters

423744-59-6
DCC4942 Stg -001

Novel RBP4 antagonist for treatment of Stargardt disease

DCC4943 Stictic Acid

Natural anti-feline infectious peritonitis virus (FIPV) agent, specifically targeting the 3CLpro of FIPV and inhibiting its replication

549-06-4
DCC4944 Sting Agonist 11

Novel non-nucleotide STING agonist, demonstrating antitumor activity when dosed intratumorally in a syngeneic mouse model

DCC4945 Sting Inhibitor C-171

Novel covalent antagonist of hsSTING

DCC4946 Stk-15

Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor

844651-66-7
DCC4947 Stk-22

Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor

843629-43-6
DCC4948 Stk295900

Dual inhibitor of topoisomerase 1 and 2, inducing G(2) arrest in the absence of DNA damage. Inhibitor of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay

4402-17-9
DCC4949 Stk508411

Novel inhibitor of the heterogeneous ribonuclear protein A18 (hnRNP A18)

664968-32-5
DCC4950 Stk630921

Novel blocker of IL-17A binding to the IL-17A receptor (IL-17RA)

1033850-63-3
DCC4951 Stk683963

Novel activator of cellular ATG4B activity

370073-65-7
DCC4952 Stock1n-65837

Potent natural modulator of human Toll-like receptor 7 (TLR7)

DCC4953 Streptolidine

Metablite of the Streptomyces antibiotics streptothricin and streptolin

29307-61-7
DCC4954 Streptozocin

Antibiotic, being used as an antineoplastic agent and to induce diabetes in experimental animals

18883-66-4
Page 1096 / Total 1149 FirstPrevNextLastGoto